The expert panel discusses why intravenous iron replacement used to be associated with unacceptable toxicity and has become much more tolerable over time.
Intravenous iron replacement has become a major component of the therapeutic armamentarium for iron deficiency (ID) and iron deficiency anemia (IDA). In the earlier days formulations were associated with unacceptable toxicity. What has changed over the years?